Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
Here's a roundup of top developments in the biotech space over the last 24 hours:
IGM Biosciences Advances Novel Antibody IGM-6268 Into Clinical Trials For The Treatment And Prevention Of COVID-19
IGM Biosciences, Inc. (NASDAQ:IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced its progress in two Phase 1 clinical trials evaluating IGM-6268,
10 Biggest Price Target Changes For Thursday
Stifel cut the price target on Under Armour, Inc.. (NYSE: UAA) from $30 to $24. Under Armour shares fell 0.7% to $22.22 in pre-market trading.
HC Wainwright & Co. Maintains Buy on IGM Biosciences, Lowers Price Target to $76
HC Wainwright & Co. analyst Robert Burns maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and lowers the price target from $114 to $76.
